MedPath

Transversalis Fascia Plane Block for Iliac Bone Graft in Children

Not Applicable
Recruiting
Conditions
Postoperative Pain, Acute
Interventions
Procedure: transversus abdominis plane block
Procedure: transversalis fascial plane block
Registration Number
NCT06403462
Lead Sponsor
Seoul National University Hospital
Brief Summary

The purpose of this study is to determine which method is more effective in postoperative pain control in children undergoing iliac bone grafting for alveoloplasty under general anesthesia: ultrasound-guided transverse abdominal blockade or transversalis fascia plane block

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Children aged 7 years and older but under 18 undergoing iliac bone grafting for alveoloplasty
Exclusion Criteria
  • Patients with diseases that affect pain sensitivity differently from the general population (e.g., congenital insensitivity to pain with anhidrosis, complex regional pain syndrome, etc.)
  • Cases where there is difficulty in expressing pain (due to cognitive or functional deficits, or limited ability to communicate)
  • Unstable vital signs (heart rate, blood pressure)
  • Common contraindications for Ropivacaine: 1) Patients with a history of hypersensitivity to this drug or other amide local anesthetics, 2) Patients in a state of major bleeding or shock, 3) Patients with inflammation at or around the site of administration, 4) Patients with sepsis, 5) Intravenous regional anesthesia (Bier block)
  • History of allergy to opioid medications
  • Severe renal impairment (Creatinine >3.0mg/dL)
  • Severe liver function abnormalities (aspartate transaminase > 120 unit/L, alanine aminotransferase > 120 unit/L)
  • Peripheral nervous system disorders
  • Other cases deemed unsuitable by the researcher

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
transversus abdominis plane blocktransversus abdominis plane block-
transversalis fascial plane blocktransversalis fascial plane block-
Primary Outcome Measures
NameTimeMethod
total consumption of opioid (mcg/kg)from the end of surgery up to 24 hours later

total opioid consumption at 24 hours after the end of surgery

Secondary Outcome Measures
NameTimeMethod
The incidence of side effects of analgesic medications (percent)within 24 hours after the end of surgery

Analgesic-related side effects (nausea, vomiting, constipation, pruritis, dizziness, dry mouth, somnolence, etc.) within 24 hours after surgery.

Postoperative Pain scoreat 30 minutes, 1 hour, 3 hours, 6 hours, 24 hours after the end of surgery

Pain scores is assessed by Numerical Rating Scale, which requires the patient to rate their pain on a defined scale. For example, 0-10 where 0 is no pain and 10 is the worst pain imaginable

Total consumption of non-opioid (mg/kg)within 24 hours after the end of surgery

Non-opioid analgesics usage per body weight within 24 hours after surgery

Satisfaction scoreat 24 hours after the end of surgery

Patient satisfaction score (0-100 points, with 100 being very satisfied and 0 being very dissatisfied).

Procedure time (min)within 10 minutes after the end of surgery

total procedure time from needle puncture to the end of block

Cold sensationat 30 minutes after the end of surgery

Evaluation of the distribution of lost cold sensation in the skin in the recovery room (Dermatomal distribution of the loss of cold sensation using an alcohol swab at post-anesthesia care unit, assessed by a blinded assessor in the Post Anesthesia Care Unit).

Sleep quality scoreat 24 hours after the end of surgery

Quality of sleep on the day of operation (satisfaction score, 0-100 points, with 100 being very satisfied and 0 being very dissatisfied).

First ambulation (hours)within 24 hours after the end of surgery

Time to first ambulation (hours)

Trial Locations

Locations (1)

Seoul National University Children's Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath